| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.65▼ | 4.65▼ | 4.65▼ | 4.56▲ | 4.62▼ |
| MA10 | 4.68▼ | 4.67▼ | 4.65▼ | 4.60▲ | 4.89▼ |
| MA20 | 4.66▼ | 4.64▼ | 4.63▼ | 4.62▼ | 5.11▼ |
| MA50 | 4.63▼ | 4.49▲ | 4.50▲ | 4.93▼ | 4.56▲ |
| MA100 | 4.49▲ | 4.57▲ | 4.62▲ | 5.09▼ | N/A |
| MA200 | 4.57▲ | 4.70▼ | 4.98▼ | 4.59▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.012▼ | -0.003▼ | 0.016▲ | N/A |
| RSI | 46.463▼ | 51.433▲ | 52.931▲ | 46.659▼ | N/A |
| STOCH | 25.135 | 34.936 | 47.660 | 48.323 | 28.663 |
| WILL %R | -82.143▼ | -82.143▼ | -79.310▼ | -40.217 | -74.057 |
| CCI | -83.149 | -60.987 | -43.656 | 8.066 | -55.561 |
|
Wednesday, September 30, 2020 04:32 AM
CAMBRIDGE, Mass.--(Business Wire)--Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic ...
|
|
Tuesday, September 29, 2020 10:25 AM
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/20 | 4.70 | 4.78 | 4.55 | 4.62 | 119,400 |
| 29/09/20 | 4.62 | 4.76 | 4.56 | 4.69 | 75,300 |
| 28/09/20 | 4.82 | 4.82 | 4.50 | 4.64 | 142,000 |
| 25/09/20 | 4.31 | 4.75 | 4.31 | 4.71 | 157,200 |
| 24/09/20 | 4.435 | 4.435 | 4.07 | 4.12 | 142,700 |
| 23/09/20 | 4.63 | 4.63 | 4.28 | 4.29 | 93,100 |
| 22/09/20 | 4.61 | 4.74 | 4.16 | 4.70 | 242,800 |
| 21/09/20 | 4.72 | 4.72 | 4.51 | 4.66 | 168,091 |
| 18/09/20 | 4.80 | 4.95 | 4.70 | 4.81 | 526,193 |
| 17/09/20 | 4.69 | 4.85 | 4.63 | 4.775 | 102,702 |
|
|
||||
|
|
||||
|
|